Multiplexed magnetic nanoparticle-antibody conjugates (MNPs-ABS) based prognostic detection of ovarian cancer biomarkers, CA-125, β-2M and ApoA1 using fluorescence spectroscopy with comparison of surface plasmon resonance (SPR) analysis.
首次提出基于多联磁性纳米颗粒-抗体偶联物(MNPs-Abs)的荧光光谱系统,用于血清 CA-125、β2-微球蛋白(β2-M)和载脂蛋白 A1(ApoA1)检测,以早期诊断卵巢癌。通过 EDC/NHS 化学将单克隆抗体共价固定于羧基化 Fe3O4 磁性纳米颗粒表面,并用 Alexa 405/532/680 标记多克隆抗体作为荧光标记...